News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,188 Results
Type
Article (39944)
Company Profile (640)
Press Release (650604)
Section
Business (205139)
Career Advice (2360)
Deals (37700)
Drug Delivery (106)
Drug Development (80669)
Employer Resources (170)
FDA (16002)
Job Trends (15465)
News (347099)
Policy (31349)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2116)
Academic (1)
Accelerated approval (2)
Adcomms (21)
Allergies (78)
Alliances (49411)
ALS (80)
Alzheimer's disease (1341)
Antibody-drug conjugate (ADC) (116)
Approvals (15969)
Artificial intelligence (241)
Autoimmune disease (14)
Automation (12)
Bankruptcy (374)
Best Places to Work (11579)
BIOSECURE Act (21)
Biosimilars (89)
Biotechnology (438)
Bladder cancer (53)
Brain cancer (22)
Breast cancer (224)
Cancer (1780)
Cardiovascular disease (137)
Career advice (1963)
Career pathing (31)
CAR-T (132)
Cell therapy (395)
Cervical cancer (14)
Clinical research (65188)
Collaboration (733)
Compensation (381)
Complete response letters (27)
COVID-19 (2481)
CRISPR (36)
C-suite (190)
Cystic fibrosis (98)
Data (1699)
Decentralized trials (2)
Denatured (6)
Depression (43)
Diabetes (224)
Diagnostics (6579)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (41)
Drug discovery (116)
Drug pricing (104)
Drug shortages (24)
Duchenne muscular dystrophy (63)
Earnings (83858)
Editorial (31)
Employer branding (24)
Employer resources (147)
Events (114374)
Executive appointments (614)
FDA (16951)
Featured Employer (69)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (651)
Gene editing (94)
Generative AI (29)
Gene therapy (267)
GLP-1 (716)
Government (3643)
Grass and pollen (4)
Guidances (41)
Healthcare (17724)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (97)
Indications (24)
Infectious disease (2601)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (71)
Interviews (447)
IPO (17292)
IRA (43)
Job creations (4375)
Job search strategy (1644)
Kidney cancer (9)
Labor market (25)
Layoffs (513)
Leadership (17)
Legal (7713)
Liver cancer (66)
Lung cancer (261)
Lymphoma (112)
Machine learning (2)
Management (59)
Manufacturing (269)
MASH (55)
Medical device (13911)
Medtech (13916)
Mergers & acquisitions (20816)
Metabolic disorders (596)
Multiple sclerosis (62)
NASH (18)
Neurodegenerative disease (76)
Neuropsychiatric disorders (27)
Neuroscience (1800)
NextGen: Class of 2025 (6554)
Non-profit (3532)
Northern California (2240)
Now hiring (36)
Obesity (333)
Opinion (249)
Ovarian cancer (59)
Pain (74)
Pancreatic cancer (70)
Parkinson's disease (120)
Partnered (17)
Patents (180)
Patient recruitment (82)
Peanut (47)
People (59289)
Pharmaceutical (132)
Pharmacy benefit managers (17)
Phase I (20362)
Phase II (28944)
Phase III (21597)
Pipeline (815)
Podcasts (50)
Policy (107)
Postmarket research (2239)
Preclinical (8422)
Press Release (68)
Prostate cancer (84)
Psychedelics (36)
Radiopharmaceuticals (258)
Rare diseases (347)
Real estate (6086)
Recruiting (67)
Regulatory (21767)
Reports (35)
Research institute (2130)
Resumes & cover letters (366)
Rett syndrome (2)
RNA editing (1)
RSV (39)
Schizophrenia (69)
Series A (121)
Series B (73)
Service/supplier (26)
Sickle cell disease (51)
Southern California (1893)
Special edition (15)
Sponsored (28)
Startups (3945)
State (2)
Stomach cancer (11)
Supply chain (61)
The Weekly (44)
United States (19906)
Vaccines (644)
Venture capitalists (35)
Webinars (13)
Weight loss (239)
Women's health (24)
Worklife (16)
Date
Today (205)
Last 7 days (903)
Last 30 days (3184)
Last 365 days (36100)
2025 (5971)
2024 (36808)
2023 (41419)
2022 (52252)
2021 (56135)
2020 (53859)
2019 (45694)
2018 (34934)
2017 (34134)
2016 (33123)
2015 (38772)
2014 (31374)
2013 (26159)
2012 (27787)
2011 (28134)
2010 (25841)
Location
Africa (798)
Alabama (54)
Alaska (7)
Arizona (167)
Arkansas (12)
Asia (42041)
Australia (6940)
California (5174)
Canada (1773)
China (430)
Colorado (235)
Connecticut (251)
Delaware (109)
Europe (92734)
Florida (723)
Georgia (175)
Hawaii (1)
Idaho (60)
Illinois (439)
India (23)
Indiana (286)
Iowa (8)
Japan (127)
Kansas (99)
Kentucky (24)
Louisiana (10)
Maine (63)
Maryland (719)
Massachusetts (4070)
Michigan (216)
Minnesota (358)
Mississippi (2)
Missouri (74)
Montana (30)
Nebraska (24)
Nevada (54)
New Hampshire (63)
New Jersey (1457)
New Mexico (29)
New York (1463)
North Carolina (972)
North Dakota (7)
Northern California (2240)
Ohio (180)
Oklahoma (11)
Oregon (43)
Pennsylvania (1138)
Puerto Rico (7)
Rhode Island (26)
South America (1181)
South Carolina (13)
South Dakota (1)
Southern California (1893)
Tennessee (84)
Texas (741)
Utah (158)
Virginia (130)
Washington D.C. (57)
Washington State (512)
West Virginia (3)
Wisconsin (49)
691,188 Results for "cole parmer instrument company acquired by fisher scientific international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Cole-Parmer Is Back in Peristaltic Pumps
Cole-Parmer, an Antylia Scientific company, is pleased to reintroduce peristaltic pumps to enhance its industry-leading line of fluid handling solutions.
June 13, 2024
·
2 min read
BioMidwest
Cole-Parmer Re-launches Fluid Handling Product Line
Cole-Parmer, an Antylia Scientific company, is launching an all-new range of industry-leading fluid handling solutions initially comprised of tubing, fittings, parts, and accessories to suit a diverse array of research and production needs.
April 8, 2024
·
1 min read
Press Releases
Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business
February 26, 2025
·
8 min read
Press Releases
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Alopecia Areata
February 5, 2025
·
3 min read
Press Releases
Thermo Fisher Scientific Elects New Director to Board
February 19, 2025
·
2 min read
Business
Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs
To support a wider range of ion chromatography analysis with one instrument, Thermo Fisher Scientific Inc., today launched the Thermo Scientific™ Dionex™ Inuvion™ Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes.
February 14, 2024
·
3 min read
Press Releases
Thermo Fisher Scientific Launches CorEvitas Clinical Registry and Biorepository in Systemic Lupus Erythematosus
February 26, 2025
·
3 min read
Press Releases
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results
January 30, 2025
·
18 min read
Press Releases
Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B
February 26, 2025
·
6 min read
Press Releases
Thermo Fisher Scientific’s Olink Platform Selected for World’s Largest Human Proteome Study
January 10, 2025
·
4 min read
1 of 69,119
Next
